Moderna Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Moderna, Inc. income statement - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue3.246.8519.2618.470.270.060.14
Cost of Revenue6.019.548.714.610.010.000.00
Gross Profit-2.77-2.6910.5513.860.270.060.14
Operating Expenses
Research & Development4.544.853.301.991.370.500.45
Selling, General & Administrative1.171.551.130.570.190.110.09
Operating Expenses1.171.551.130.571.560.610.55
Operating Income-3.95-4.249.4213.30-0.76-0.55-0.41
Other Income/Expense
Interest Income0.430.420.200.020.030.000.03
Interest Expense-0.02-0.04-0.03-0.02-0.010.000.00
Other Income/Expense-0.01-0.01-0.02-0.010.010.010.00
Income
Income Before Tax-3.61-3.949.5813.29-0.74-0.51-0.38
Income Tax Expense-0.050.771.211.080.000.000.00
Net Income-3.56-4.718.3612.20-0.75-0.51-0.38
Net Income - Continuous Operations-3.56-4.718.3612.200.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-3.76-3.629.7713.53-0.73-0.48-0.36
EBIT-3.95-4.249.4213.30-0.76-0.51-0.38
Depreciation & Amortization0.190.620.350.230.030.030.00
Earnings Per Share
Basic EPS-9.00-12.0021.0030.00-2.00-2.00-5.00
Diluted EPS-9.00-12.0020.0028.00-2.00-2.00-5.00
Basic Shares Outstanding0.380.380.390.400.380.330.08
Diluted Shares Outstanding0.380.380.420.430.380.330.08